Cigna sees strong annual profit on lower costs, pharmacy benefit strength
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
CIGNA (CI) PT Raised to $400 at Cantor Fitzgerald
May 3, 2024 6:57 AM EDTCantor Fitzgerald analyst Sarah James raised the price target on CIGNA (NYSE: CI) to $400.00 (from $384.00) while maintaining a Overweight rating.
The analyst comments "We are raising our price target from $384 to $400. This represents a 2025E P/E multiple of 12.2x from our previous... More
CIGNA (CI) PT Raised to $384 at RBC Capital
May 3, 2024 6:51 AM EDTRBC Capital analyst Ben Hendrix raised the price target on CIGNA (NYSE: CI) to $384.00 (from $383.00) while maintaining a Outperform rating.
The analyst comments "We are puzzled by share weakness on Thursday, following Cigna's solid first quarter beat and raise. We believe the sell-off is... More
